Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
308
-
Total 13F shares, excl. options
-
105,780,468
-
Shares change
-
+7,248,394
-
Total reported value, excl. options
-
$4,275,244,101
-
Value change
-
+$258,303,501
-
Put/Call ratio
-
161%
-
Number of buys
-
133
-
Number of sells
-
180
-
Price
-
$40.42
Institutional Holders of ISIS PHARMACEUTICALS INC - COM (ISIS) as of Q3 2015
As of 30 Sep 2015 ISIS PHARMACEUTICALS INC - COM (ISIS) had 308 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 105,780,468 shares of stock of the company.
Largest 10 holders included FMR LLC, Clearbridge Investments, LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BB BIOTECH AG, WADDELL & REED FINANCIAL INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, and FIRST TRUST ADVISORS LP.
This table shows 308 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.